| Title: | Crystallization and preliminary X-ray diffraction analysis of the Fab portion of the Alzheimer's disease immunotherapy candidate bapineuzumab complexed with amyloid-beta |
| Authors: | Crespi, GAN Ascher, DB Parker, MW Miles, LA |
| Issue Year: | 2014 |
| Publisher | WILEY-BLACKWELL |
| Series | ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS: 70(Pt 3):374-7 |
| Abstract | Bapineuzumab (AAB-001) and its derivative (AAB-003) are humanized versions of the anti-A beta murine antibody 3D6 and are immunotherapy candidates in Alzheimer's disease. The common Fab fragment of these immunotherapies has been expressed, purified and crystallized in complex with beta-amyloid peptides (residues 1-8 and 1-28). Diffraction data at high resolution were acquired from crystals of Fab-A beta(8) (2.0 angstrom) and Fab-A beta(28) (2.2 angstrom) complexes at the Australian Synchrotron. Both crystal forms belonged to the primitive orthorhombic space group P2(1)22(1). |
| URI: | https://publications.svi.edu.au/publications/1769 |
| Other Identifiers | 10.1107/S2053230X14001642 |
| Publication type | Article |
| Grant ID | GNT1021645; GNT1021935 |
| Find it online | not available |
| Download | Download publication |